Combined electric field and ultrasound therapy as a novel anti-tumour treatment

J Larkin, D Soden, C Collins, M Tangney, JM Preston, LJ Russell, Anthony McHale, C Dunne, GC O'Sullivan

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The permeabilising effects of electric pulses on cell membranes and the use of ultrasound energy of various intensities, for both thermal effects and enhancement of drug and gene delivery, have led to extensive research into the potential applications of these systems in the development of novel anti-cancer treatments. In the present study we have demonstrated for the first time that the application of brief electric pulses `sensitises' tumour cells to the effects of low intensity ultrasound. The studies were conducted in human tumours established in athymic nude mice and in many instances resulted in the reduction of tumour mass. The combined electric field and ultrasound approach (CEFUS) was applied in vivo to a murine colon adenocarcinoma (C26) and a human oesophageal adenocarcinoma (OE19). The experiments performed demonstrated the anti-tumour effects of the combined therapy. Varying the electrosensitisation parameters used (voltage, waveform, electrode type) contributed to optimise the procedure. Exponential electric pulses with a peak of 1000 V/cm were initially used, but square wave pulses (1000 V/cm, 1ms, x2, 1Hz) were found to be just as effective. All ultrasound application parameters were kept constant during the study. The growth rate of C26 tumours treated with CEFUS was significantly reduced with respect to untreated controls at day 7 (96% of average initial tumour volume in CEFUS group versus 615% for controls, P < 0.05). Similar reduction was observed in OE19 tumours treated with CEFUS by day 4 (82% versus 232%, P < 0.032). Our preliminary data suggest that this novel technology could potentially be of wide application in clinical practice for the treatment of solid tumours and is worth further investigation. (c) 2005 Elsevier Ltd. All rights reserved.
LanguageEnglish
Pages1339-1348
JournalEuropean Journal of Cancer
Volume41
Issue number9
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Neoplasms
Therapeutics
Nude Mice
Adenocarcinoma
Tumor Burden
Electrodes
Colon
Hot Temperature
Cell Membrane
Technology
Growth
Research
Pharmaceutical Preparations
Genes

Cite this

Larkin, J., Soden, D., Collins, C., Tangney, M., Preston, JM., Russell, LJ., ... O'Sullivan, GC. (2005). Combined electric field and ultrasound therapy as a novel anti-tumour treatment. European Journal of Cancer, 41(9), 1339-1348. https://doi.org/10.1016/j.ejca.2005.01.025
Larkin, J ; Soden, D ; Collins, C ; Tangney, M ; Preston, JM ; Russell, LJ ; McHale, Anthony ; Dunne, C ; O'Sullivan, GC. / Combined electric field and ultrasound therapy as a novel anti-tumour treatment. In: European Journal of Cancer. 2005 ; Vol. 41, No. 9. pp. 1339-1348.
@article{965a961c9001423d9259bb55c5f957c2,
title = "Combined electric field and ultrasound therapy as a novel anti-tumour treatment",
abstract = "The permeabilising effects of electric pulses on cell membranes and the use of ultrasound energy of various intensities, for both thermal effects and enhancement of drug and gene delivery, have led to extensive research into the potential applications of these systems in the development of novel anti-cancer treatments. In the present study we have demonstrated for the first time that the application of brief electric pulses `sensitises' tumour cells to the effects of low intensity ultrasound. The studies were conducted in human tumours established in athymic nude mice and in many instances resulted in the reduction of tumour mass. The combined electric field and ultrasound approach (CEFUS) was applied in vivo to a murine colon adenocarcinoma (C26) and a human oesophageal adenocarcinoma (OE19). The experiments performed demonstrated the anti-tumour effects of the combined therapy. Varying the electrosensitisation parameters used (voltage, waveform, electrode type) contributed to optimise the procedure. Exponential electric pulses with a peak of 1000 V/cm were initially used, but square wave pulses (1000 V/cm, 1ms, x2, 1Hz) were found to be just as effective. All ultrasound application parameters were kept constant during the study. The growth rate of C26 tumours treated with CEFUS was significantly reduced with respect to untreated controls at day 7 (96{\%} of average initial tumour volume in CEFUS group versus 615{\%} for controls, P < 0.05). Similar reduction was observed in OE19 tumours treated with CEFUS by day 4 (82{\%} versus 232{\%}, P < 0.032). Our preliminary data suggest that this novel technology could potentially be of wide application in clinical practice for the treatment of solid tumours and is worth further investigation. (c) 2005 Elsevier Ltd. All rights reserved.",
author = "J Larkin and D Soden and C Collins and M Tangney and JM Preston and LJ Russell and Anthony McHale and C Dunne and GC O'Sullivan",
year = "2005",
month = "6",
doi = "10.1016/j.ejca.2005.01.025",
language = "English",
volume = "41",
pages = "1339--1348",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier",
number = "9",

}

Larkin, J, Soden, D, Collins, C, Tangney, M, Preston, JM, Russell, LJ, McHale, A, Dunne, C & O'Sullivan, GC 2005, 'Combined electric field and ultrasound therapy as a novel anti-tumour treatment', European Journal of Cancer, vol. 41, no. 9, pp. 1339-1348. https://doi.org/10.1016/j.ejca.2005.01.025

Combined electric field and ultrasound therapy as a novel anti-tumour treatment. / Larkin, J; Soden, D; Collins, C; Tangney, M; Preston, JM; Russell, LJ; McHale, Anthony; Dunne, C; O'Sullivan, GC.

In: European Journal of Cancer, Vol. 41, No. 9, 06.2005, p. 1339-1348.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combined electric field and ultrasound therapy as a novel anti-tumour treatment

AU - Larkin, J

AU - Soden, D

AU - Collins, C

AU - Tangney, M

AU - Preston, JM

AU - Russell, LJ

AU - McHale, Anthony

AU - Dunne, C

AU - O'Sullivan, GC

PY - 2005/6

Y1 - 2005/6

N2 - The permeabilising effects of electric pulses on cell membranes and the use of ultrasound energy of various intensities, for both thermal effects and enhancement of drug and gene delivery, have led to extensive research into the potential applications of these systems in the development of novel anti-cancer treatments. In the present study we have demonstrated for the first time that the application of brief electric pulses `sensitises' tumour cells to the effects of low intensity ultrasound. The studies were conducted in human tumours established in athymic nude mice and in many instances resulted in the reduction of tumour mass. The combined electric field and ultrasound approach (CEFUS) was applied in vivo to a murine colon adenocarcinoma (C26) and a human oesophageal adenocarcinoma (OE19). The experiments performed demonstrated the anti-tumour effects of the combined therapy. Varying the electrosensitisation parameters used (voltage, waveform, electrode type) contributed to optimise the procedure. Exponential electric pulses with a peak of 1000 V/cm were initially used, but square wave pulses (1000 V/cm, 1ms, x2, 1Hz) were found to be just as effective. All ultrasound application parameters were kept constant during the study. The growth rate of C26 tumours treated with CEFUS was significantly reduced with respect to untreated controls at day 7 (96% of average initial tumour volume in CEFUS group versus 615% for controls, P < 0.05). Similar reduction was observed in OE19 tumours treated with CEFUS by day 4 (82% versus 232%, P < 0.032). Our preliminary data suggest that this novel technology could potentially be of wide application in clinical practice for the treatment of solid tumours and is worth further investigation. (c) 2005 Elsevier Ltd. All rights reserved.

AB - The permeabilising effects of electric pulses on cell membranes and the use of ultrasound energy of various intensities, for both thermal effects and enhancement of drug and gene delivery, have led to extensive research into the potential applications of these systems in the development of novel anti-cancer treatments. In the present study we have demonstrated for the first time that the application of brief electric pulses `sensitises' tumour cells to the effects of low intensity ultrasound. The studies were conducted in human tumours established in athymic nude mice and in many instances resulted in the reduction of tumour mass. The combined electric field and ultrasound approach (CEFUS) was applied in vivo to a murine colon adenocarcinoma (C26) and a human oesophageal adenocarcinoma (OE19). The experiments performed demonstrated the anti-tumour effects of the combined therapy. Varying the electrosensitisation parameters used (voltage, waveform, electrode type) contributed to optimise the procedure. Exponential electric pulses with a peak of 1000 V/cm were initially used, but square wave pulses (1000 V/cm, 1ms, x2, 1Hz) were found to be just as effective. All ultrasound application parameters were kept constant during the study. The growth rate of C26 tumours treated with CEFUS was significantly reduced with respect to untreated controls at day 7 (96% of average initial tumour volume in CEFUS group versus 615% for controls, P < 0.05). Similar reduction was observed in OE19 tumours treated with CEFUS by day 4 (82% versus 232%, P < 0.032). Our preliminary data suggest that this novel technology could potentially be of wide application in clinical practice for the treatment of solid tumours and is worth further investigation. (c) 2005 Elsevier Ltd. All rights reserved.

U2 - 10.1016/j.ejca.2005.01.025

DO - 10.1016/j.ejca.2005.01.025

M3 - Article

VL - 41

SP - 1339

EP - 1348

JO - European Journal of Cancer

T2 - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 9

ER -

Larkin J, Soden D, Collins C, Tangney M, Preston JM, Russell LJ et al. Combined electric field and ultrasound therapy as a novel anti-tumour treatment. European Journal of Cancer. 2005 Jun;41(9):1339-1348. https://doi.org/10.1016/j.ejca.2005.01.025